+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Group Typing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Blood Group Typing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Blood Group Typing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 4989627
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Group Typing Market grew from USD 3.63 billion in 2024 to USD 3.93 billion in 2025. It is expected to continue growing at a CAGR of 7.85%, reaching USD 5.72 billion by 2030.

Blood group typing stands as a cornerstone in transfusion medicine, underpinning the safety and efficacy of blood transfusions, organ transplants and prenatal care. With advances in immunohematology and automation driving rapid evolution, stakeholders across the healthcare continuum demand precise, reliable and cost-effective solutions. Over the past decade, the integration of digital laboratory information systems and the emergence of molecular assays have reshaped workflows in blood banks and diagnostic centers. As patient populations grow and regulatory requirements tighten, decision-makers must navigate a complex environment of consumables, instruments and reagents while ensuring high throughput and minimal error. This report synthesizes the latest developments, spotlighting transformative trends, tariff impacts and segmentation dynamics to equip experts and leaders with the insights needed to optimize procurement, streamline operations and uphold the highest standards of transfusion safety.

Transformative Technology, Automation and Market Consolidation Trends

The blood group typing landscape has undergone a series of transformative shifts, driven by technological breakthroughs and evolving clinical demands. Automation has moved beyond traditional semi-automated analyzers to fully integrated platforms linked directly to laboratory information management systems, enabling real-time data exchange and reducing manual intervention. Simultaneously, molecular blood typing methods are gaining traction, offering genotypic precision that complements phenotypic assays and enhances compatibility assessments. Point-of-care testing devices have become more compact and user-friendly, empowering smaller clinics and remote facilities to conduct rapid ABO and Rh group determinations.

Regulatory reforms have further propelled change, with harmonized guidelines promoting standardized reagent quality and assay validation across regions. Collaborations between diagnostic manufacturers and software providers have led to AI-driven pattern recognition tools that flag atypical serological responses, boosting accuracy in weak D classification. In parallel, strategic alliances and mergers have consolidated key players, fostering economies of scale in research and development while streamlining distribution networks. These converging forces have redefined expectations for speed, precision and cost efficiency in blood group typing.

Assessing the Effects of 2025 US Tariffs on Supply Chain and Costs

The implementation of cumulative United States tariffs in 2025 has introduced multifaceted challenges for import-dependent segments of the blood group typing market. Consumable components such as test strips and specialized microplates now face elevated duty rates that have incrementally increased per-unit costs. This development has prompted some laboratories to renegotiate supplier contracts and explore domestic manufacturing options to contain expenditure. In the instruments category, where analyzers and their proprietary modules often cross multiple tariff thresholds, procurement cycles have slowed as buyers reassess total cost of ownership and delayed non-critical upgrades.

Reagent suppliers have also felt the impact, particularly those relying on imported raw materials for antisera and custom serum formulations. Tariff-induced cost pressures are being partially offset through streamlined reagent kits that consolidate multiple assay steps, though these innovations require fresh rounds of validation and staff training. On the positive side, the current tariff landscape is catalyzing investment in local production facilities, offering a medium-term pathway to mitigate reliance on cross-border shipments. Ultimately, supply chain agility and portfolio diversification have emerged as essential strategies for sustaining access to high-quality blood grouping solutions under the new fiscal regime.

Deep Dive into Product, Method and End-User Segmentation

Insights derived from product-type segmentation underscore the importance of tailoring offerings to distinct user requirements. Consumables remain a cornerstone revenue stream, with high-volume items such as microplates, test strips and tubes driving recurring purchases for routine serological assays. Instruments capture significant capital expenditure, particularly through investments in analyzers that range from semi-automated to fully automated configurations. Automated analyzers command premium positioning by delivering scalable throughput and reduced hands-on time, while semi-automated systems continue to satisfy smaller laboratories seeking a balance between cost and functionality. Meanwhile, the reagents segment-comprising antisera, kits and serum-serves as the foundation of assay specificity, with kit formats gaining favor for their standardized workflows.

When viewed through the lens of testing methodology, ABO blood grouping retains its essential role in initial compatibility screening, whereas Rh blood grouping and weak D testing are becoming increasingly critical in prenatal and transplant settings. End-user analysis reveals that blood banks require robust high-throughput solutions to manage large donor volumes, diagnostic laboratories prioritize flexible platforms capable of handling variable workloads, hospitals demand rapid turnaround times for emergent cases and research institutes focus on advanced genotyping capabilities for novel antibody detection. This multifaceted segmentation approach helps stakeholders align product development and marketing strategies with the nuanced needs of each usage scenario.

Comparative Regional Dynamics and Adoption Patterns

Regional dynamics reveal distinct patterns of adoption and strategic focus. In the Americas, well-established infrastructure and favorable reimbursement frameworks support early uptake of cutting-edge automated analyzers and high-complexity reagents. Laboratories in North America lead in implementing AI-enabled data review tools, while Latin American centers emphasize cost-effective consumable solutions due to budgetary constraints. Across Europe, Middle East & Africa, regulatory harmonization efforts-particularly within the European Union and select Gulf Cooperation Council states-have driven widespread adoption of standardized kits and reagents, although divergent reimbursement models continue to influence purchasing decisions. Finally, the Asia-Pacific region exhibits the fastest expansion rate, fueled by increasing healthcare investment in China, India and Southeast Asia, alongside government initiatives to bolster blood safety and self-sufficiency in medical supplies.

Profiling Leading Innovators and Established Suppliers

The competitive landscape features a diverse array of innovators and established suppliers. Agena Bioscience, Inc. continues to push the boundaries of mass spectrometry applications in blood group genotyping, while Atlas Medical GmbH has carved out a niche in molecular assay development. AXO Science SAS leverages microarray platforms to offer multiplexed antibody screening, and BAG Health Care GmbH specializes in advanced automated analyzer lines. Beckman Coulter, Inc. draws on its global distribution network to deliver integrated solutions spanning both instruments and reagents, whereas Bio-Rad Laboratories, Inc. emphasizes high-sensitivity antisera and quality control materials. Biorex Diagnostics focuses on user-friendly reagent kits, and Cardinal Health capitalizes on its logistics expertise to streamline supply chain operations.

Genome Diagnostics B.V. offers next-generation sequencing tools geared toward rare blood group variants, and Grifols, S.A. remains a leader in plasma-derived antisera. Hemo Bioscience, Inc. drives innovation in automated sample processing, while Lorne Laboratories Limited leads in preanalytical consumable design. Merck KGaA extends its life-science portfolio with specialized reagents, and Quotient Suisse SA introduces real-time donor-screening platforms. Rapid Labs Ltd concentrates on point-of-care blood typing devices, whereas Thermo Fisher Scientific, Inc. provides end-to-end solutions that integrate hardware, software and service agreements. Together, these companies define a marketplace characterized by rapid technological advancement and strategic partnerships.

Strategic Actions to Strengthen Market Position

To navigate the evolving landscape and capitalize on emerging opportunities, industry leaders should adopt a multi-pronged strategy. First, accelerating investment in fully automated analyzers and AI-enabled software will address growing demands for throughput and accuracy. Second, diversifying supply chains through partnerships with domestic manufacturers can reduce exposure to external tariffs and logistical bottlenecks. Third, expanding reagent portfolios to include high-specificity kits tailored for weak D classification and molecular genotyping will meet advanced clinical requirements.

Fourth, forging collaborative arrangements with regulatory bodies can streamline product approvals and ensure compliance across regions. Fifth, deploying targeted training programs for laboratory staff will maximize the benefits of new platforms and minimize implementation delays. Finally, pursuing strategic alliances between instrument and software providers will create integrated ecosystems that enhance customer loyalty and simplify procurement processes. By executing these initiatives in parallel, organizations can secure a robust position in the dynamic blood group typing market.

Executive Summary and Strategic Imperatives

The blood group typing sector stands at the intersection of technological innovation, regulatory change and shifting economic policies. Automation and molecular methods are redefining standard practices, while 2025 tariff adjustments necessitate agile supply chain strategies. Segmentation analysis highlights the differential needs of consumable, instrument and reagent users, and regional insights reveal varied adoption curves across the Americas, Europe, Middle East & Africa and Asia-Pacific. A competitive pulse check affirms that leading firms excel through integrated solutions, strategic partnerships and continuous product development. In this context, market participants who align investments with these core dynamics and embrace operational flexibility will be best positioned to drive efficiency, ensure patient safety and deliver sustained growth.

Market Segmentation & Coverage

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Consumables
    • Microplates
    • Test Strips
    • Tubes
  • Instruments
    • Analyzers
      • Automated Analyzers
      • Semi-Automated Analyzers
  • Reagents
    • Antisera
    • Kits
    • Serum
  • ABO Blood Grouping
  • Rh Blood Grouping
    • Weak D Testing
  • Blood Banks
  • Diagnostic Laboratories
  • Hospitals
  • Research Institutes

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Blood Group Typing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Agena Bioscience, Inc.
  • Atlas Medical GmbH
  • AXO Science SAS
  • BAG Health Care GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc
  • Biorex Diagnostics
  • Cardinal Health
  • Genome Diagnostics B.V.
  • Grifols, S.A.
  • Hemo bioscience, Inc.
  • Lorne Laboratories Limited
  • Merck KGaA
  • Quotient Suisse SA
  • Rapid Labs Ltd
  • Thermo Fisher Scientific, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Group Typing Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Microplates
8.2.2. Test Strips
8.2.3. Tubes
8.3. Instruments
8.3.1. Analyzers
8.3.1.1. Automated Analyzers
8.3.1.2. Semi-Automated Analyzers
8.4. Reagents
8.4.1. Antisera
8.4.2. Kits
8.4.3. Serum
9. Blood Group Typing Market, by Testing Method
9.1. Introduction
9.2. ABO Blood Grouping
9.3. Rh Blood Grouping
9.3.1. Weak D Testing
10. Blood Group Typing Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes
11. Americas Blood Group Typing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Blood Group Typing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Blood Group Typing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Agena Bioscience, Inc.
14.3.2. Atlas Medical GmbH
14.3.3. AXO Science SAS
14.3.4. BAG Health Care GmbH
14.3.5. Beckman Coulter, Inc.
14.3.6. Bio-Rad Laboratories, Inc
14.3.7. Biorex Diagnostics
14.3.8. Cardinal Health
14.3.9. Genome Diagnostics B.V.
14.3.10. Grifols, S.A.
14.3.11. Hemo bioscience, Inc.
14.3.12. Lorne Laboratories Limited
14.3.13. Merck KGaA
14.3.14. Quotient Suisse SA
14.3.15. Rapid Labs Ltd
14.3.16. Thermo Fisher Scientific, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BLOOD GROUP TYPING MARKET MULTI-CURRENCY
FIGURE 2. BLOOD GROUP TYPING MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD GROUP TYPING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD GROUP TYPING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SEMI-AUTOMATED ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTISERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ABO BLOOD GROUPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY WEAK D TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 60. CANADA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. CANADA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 62. CANADA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 63. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 64. CANADA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 65. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 72. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 73. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. CHINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. CHINA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 102. CHINA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 103. CHINA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 104. CHINA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 105. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 106. CHINA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 107. CHINA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. INDIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. INDIA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. INDIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. INDIA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 112. INDIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 113. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 114. INDIA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 115. INDIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 126. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 127. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 128. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 129. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 130. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 131. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 166. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 167. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 168. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 174. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 175. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 176. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 177. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 178. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 179. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 182. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 197. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 199. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 200. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 201. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 202. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 203. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 204. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 207. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 209. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 210. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 211. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 212. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 215. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 217. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 218. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 219. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 220. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 223. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 224. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 225. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 226. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 227. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 228. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 231. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 232. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 234. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 235. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 236. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. ITALY BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 247. ITALY BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 248. ITALY BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 249. ITALY BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 250. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 251. ITALY BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 252. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 271. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 272. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 274. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 275. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 276. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. POLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. POLAND BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 279. POLAND BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 280. POLAND BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 281. POLAND BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 282. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 283. POLAND BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 284. POLAND BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. QATAR BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 287. QATAR BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 288. QATAR BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 289. QATAR BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 290. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 291. QATAR BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 292. QATAR BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 319. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 320. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 321. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 322. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 323. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 324. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 335. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 336. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 337. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 338. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 339. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 342. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 343. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 344. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 345. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 346. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 347. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY RH BLOOD GROUPING, 2018-2030 (USD MILLION)
TABLE 348. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
TABLE 355. UNITED

Companies Mentioned

  • Agena Bioscience, Inc.
  • Atlas Medical GmbH
  • AXO Science SAS
  • BAG Health Care GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc
  • Biorex Diagnostics
  • Cardinal Health
  • Genome Diagnostics B.V.
  • Grifols, S.A.
  • Hemo bioscience, Inc.
  • Lorne Laboratories Limited
  • Merck KGaA
  • Quotient Suisse SA
  • Rapid Labs Ltd
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Blood Group Typing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User - Product Image

Blood Group Typing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • Report
  • 112 Pages
  • Global
From
Blood Group Typing - Global Strategic Business Report - Product Image

Blood Group Typing - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Blood Group Typing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Group Typing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From
Blood Group Typing Market: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Image

Blood Group Typing Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • 280 Pages
  • Global
From
Blood Group Typing Market Report 2025 - Product Image

Blood Group Typing Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Blood Typing Market

The Blood Typing market within the context of Coagulation and Hemostasis Testing is a specialized field of laboratory testing that focuses on the identification of blood types and the detection of antibodies in the blood. This type of testing is used to diagnose and monitor a variety of conditions, including hemophilia, thrombosis, and other bleeding disorders. It is also used to determine compatibility for blood transfusions and organ transplants. Blood typing is typically performed using a variety of techniques, such as agglutination, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR). The Blood Typing market is a highly competitive field, with a variety of companies offering products and services. Some of the major players in the market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.